Clinical Trials Browser

Recruiting × Resectable Pancreatic Cancer × folfirinox × Clear all

NCT05529940 2024-11-27

NeoFOL-R Trial (Perioperative Versus Adjuvnat FOLFIRINOX in Resectable Pancreatic Cancer)

Phase 3 Recruiting

Gastrointestinal

Resectable Pancreatic Cancer